Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haineng Xu

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Nature Communications|February 10, 2018
Vascular niche IL-6 induces alternative macrophage activation in glioblastoma through HIF-2αQirui Wang, Zhenqiang He, Menggui Huang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 26, 2023
A B7-H4-Targeting Antibody-Drug Conjugate Shows Antitumor Activity in PARPi and Platinum-Resistant Cancers with B7-H4 ExpressionSarah B Gitto, Margaret Whicker, Gareth Davies, et al.
Research Square|February 27, 2024
Targeting <i>CCNE1</i> amplified ovarian and endometrial cancers by combined inhibition of PKMYT1 and ATRHaineng Xu, Erin George, David Gallo, et al.
Nature Communications|April 1, 2025
Targeting CCNE1 amplified ovarian and endometrial cancers by combined inhibition of PKMYT1 and ATRHaineng Xu, Erin George, David Gallo, et al.
Nature Communications|July 26, 2020
Combining PARP with ATR inhibition overcomes PARP inhibitor and platinum resistance in ovarian cancer modelsHyoung Kim, Haineng Xu, Erin George, et al.
Iscience|July 18, 2024
CHK1 inhibitor SRA737 is active in PARP inhibitor resistant and <i>CCNE1</i> amplified ovarian cancerHaineng Xu, Sarah B Gitto, Gwo-Yaw Ho, et al.
Cell Reports. Medicine|October 8, 2021
<i>CCNE1</i> copy number is a biomarker for response to combination WEE1-ATR inhibition in ovarian and endometrial cancer modelsHaineng Xu, Erin George, Yasuto Kinose, et al.
Research Square|October 16, 2023
Dual blockade of BRD4 and ATR/WEE1 pathways exploits <i>ARID1A</i> loss in clear cell ovarian cancerYasuto Kinose, Haineng Xu, Hyoung Kim, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 20, 2022
A computer-aided diagnosis system using white-light endoscopy for the prediction of conventional adenoma with high grade dysplasiaSijun Meng, Yueping Zheng, Wangyue Wang, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Nature Communications|February 10, 2018
Vascular niche IL-6 induces alternative macrophage activation in glioblastoma through HIF-2αQirui Wang, Zhenqiang He, Menggui Huang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 26, 2023
A B7-H4-Targeting Antibody-Drug Conjugate Shows Antitumor Activity in PARPi and Platinum-Resistant Cancers with B7-H4 ExpressionSarah B Gitto, Margaret Whicker, Gareth Davies, et al.
Research Square|February 27, 2024
Targeting <i>CCNE1</i> amplified ovarian and endometrial cancers by combined inhibition of PKMYT1 and ATRHaineng Xu, Erin George, David Gallo, et al.
Nature Communications|April 1, 2025
Targeting CCNE1 amplified ovarian and endometrial cancers by combined inhibition of PKMYT1 and ATRHaineng Xu, Erin George, David Gallo, et al.
Nature Communications|July 26, 2020
Combining PARP with ATR inhibition overcomes PARP inhibitor and platinum resistance in ovarian cancer modelsHyoung Kim, Haineng Xu, Erin George, et al.
Iscience|July 18, 2024
CHK1 inhibitor SRA737 is active in PARP inhibitor resistant and <i>CCNE1</i> amplified ovarian cancerHaineng Xu, Sarah B Gitto, Gwo-Yaw Ho, et al.
Cell Reports. Medicine|October 8, 2021
<i>CCNE1</i> copy number is a biomarker for response to combination WEE1-ATR inhibition in ovarian and endometrial cancer modelsHaineng Xu, Erin George, Yasuto Kinose, et al.
Research Square|October 16, 2023
Dual blockade of BRD4 and ATR/WEE1 pathways exploits <i>ARID1A</i> loss in clear cell ovarian cancerYasuto Kinose, Haineng Xu, Hyoung Kim, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 20, 2022
A computer-aided diagnosis system using white-light endoscopy for the prediction of conventional adenoma with high grade dysplasiaSijun Meng, Yueping Zheng, Wangyue Wang, et al.
Pageof 3